apheresis

(redirected from therapeutic apheresis)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for apheresis

(linguistics) omission at the beginning of a word as in 'coon' for 'raccoon' or 'till' for 'until'

a procedure in which blood is drawn and separated into its components by dialysis

References in periodicals archive ?
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.
Therapeutic apheresis (TA) procedures included plasmapheresis, photopheresis, cytapheresis, and PBSC collections from January 1, 20l3 to April 30, 2014.
Aqui et al., "Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue," Journal of Clinical Apheresis, vol.
Duranay, "Acinetobacter lwoffii Peritonitis in a Patient Receiving Continuous Ambulatory Peritoneal Dialysis," Therapeutic Apheresis and Dialysis, vol.
announced a three-year collaboration agreement with Terumo BCT Inc., a provider of blood component, therapeutic apheresis and cellular technologies.
Sometimes three to five sessions can even totally reverse a disease, and patients won't need to undertake therapeutic apheresis for life like dialysis," added Dr Al Zoebie.
Sometimes three to five sessions can totally reverse a disease, and patients won't need to undertake therapeutic apheresis for life like in the case of dialysis," added Dr Al Zoebie.
Therapeutic apheresis: A physician's hand-book (2nd ed.).
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion.
Rigdon Lentz, MD, who helped pioneer the use of therapeutic apheresis (TA) for cancer a quarter century ago.
The plant will produce the 'Plasmaflo' separator for plasmapheresis, 'Excelflo' filter for continuous renal replacement therapy (CRRT), 'Cellsorba' leukocytapheresis column, and other therapeutic apheresis devices.
They cover research in hematopoietic stem cells and blood cell engineering; novel cellular therapeutics and hemapoietic cell transplantation; molecular immunohematology, immunomodulation, and therapeutic apheresis; hemostasis in infection and host defense; platelet-pathogen interactions; organ and vascular bed-specific thrombogenesis and genetic research in thrombophilia; diagnosis and management of bleeding disorders; and challenges in blood donor recruitment and blood supply due to demographic changes.